www.ema.europa.eu Open in urlscan Pro
2600:9000:21b3:9e00:6:2114:f4c0:93a1  Public Scan

Form analysis
2 forms found in the DOM

POST

<form onsubmit="submit_site_wide_search()" accept-charset="UTF-8" class="ecl-form ecl-search-form ecl-search-form--ema ecl-site-header__search ema-u-outline" id="ema-search-global-search-box-form" method="post" _lpchecked="1">
  <label class="ecl-search-form__textfield-wrapper">
    <span class="ecl-u-sr-only">Search</span>
    <input class="ecl-search-form__textfield ecl-text-input ema-u-outline" id="edit-search-fulltext" maxlength="128" name="search_fulltext" type="text" value="">
  </label>
  <button class="ecl-button ecl-button--ema-primary ecl-button--form ecl-button--primary ecl-search-form__button form-button-submit" id="edit-submit" name="op" type="submit" value="Search">Search</button>
</form>

GET medicines

<form accept-charset="UTF-8" action="medicines" class="ecl-form ecl-u-pa-s ema-card" method="get" lpchecked="1">
  <fieldset class="ecl-fieldset">
    <div class="ema-card-title">Search for medicines</div>
    <div class="ema-card-content">Search for information on human, veterinary or herbal medicines. </div>
    <div class="ecl-form-group">
      <input type="text" class="ecl-text-input ecl-text-input--ema" id="field-ID-1" name="search_api_views_fulltext" autocomplete="OFF" aria-autocomplete="list" role="combobox" placeholder="Enter keyword">
    </div>
    <button class="ecl-button ecl-button--primary ecl-button--ema-primary ecl-u-mt-s ecl-u-f-r" value="search" type="submit">Search </button>
  </fieldset>
</form>

Text Content

An official website of the European UnionAn official EU websiteHow do you know?

All official European Union website addresses are in the europa.eu domain.

See all EU institutions and bodies

This site uses cookies to offer you a better browsing experience. Find out more
on how we use cookies.

This site uses cookies to offer you a better browsing experience. Find out more
on how we use cookies and how you can change your settings.

Accept all cookies Accept only essential cookies
Skip to main content
Search Search
Menu
 * Medicines
   Medicines
   
   
   
    * Search
    * Download
    * What we publish and when
    * Medicines under evaluation
    * National registers

 * Human regulatory
   Human regulatory
   
   
   
    * Overview
    * Research and development
    * Marketing authorisation
    * Post-authorisation
    * Herbal products

 * Veterinary regulatory
   Veterinary regulatory
   
   
   
    * Overview
    * Research and development
    * Marketing authorisation
    * Post-authorisation

 * Committees
   Committees
   
   
   
    * How the committees work
    * CHMP
    * CVMP
    * PRAC
    * COMP
    * HMPC
    * CAT
    * PDCO
    * Working parties and other groups

 * News & events
   News & events
   
   
   
    * News and press releases
    * Events
    * What's new
    * Committee highlights
    * Therapeutic areas: latest updates
    * Publications
    * Press and social media
    * Open consultations
    * RSS feeds

 * Partners & networks
   Partners & networks
   
   
   
    * EU partners
    * International activities
    * Patients and consumers
    * Healthcare professionals
    * Academia
    * Pharmaceutical industry
    * Networks
    * Health technology assessment bodies

 * About us
   About us
   
   
   
    * What we do
    * Who we are
    * How we work
    * Annual reports and work programmes
    * History of EMA
    * Careers
    * Procurement
    * Glossaries
    * About this website
    * Data protection and privacy
    * FAQs
    * Contacts

Close banner


COVID-19

All info here


QUICK LINKS

 * Latest updates
 * Vaccines
 * Treatments
 * Guidance for developers and companies


 * Reports of falsified Ozempic pens
   
   Falsified medicines |Ozempic
   
   
   REPORTS OF FALSIFIED OZEMPIC PENS
   
   
   
   
 * Reports of falsified Ozempic pens
   
   Falsified medicines |Ozempic
   
   
   REPORTS OF FALSIFIED OZEMPIC PENS
   
   EMA alerts EU patients and healthcare professionals that pre-filled pens
   falsely labelled as the diabetes medicine Ozempic have been identified at
   wholesalers in EU and the UK
   
   
 * CHMP Highlights: October 2023
   
   MEDICINES |COMMITTEES
   
   
   CHMP HIGHLIGHTS: OCTOBER 2023
   
   
   
   
 * CHMP Highlights: October 2023
   
   MEDICINES |COMMITTEES
   
   
   CHMP HIGHLIGHTS: OCTOBER 2023
   
   EMA's human medicines committee (CHMP) recommended 7 new medicines for
   approval in the EU at its October 2023 meeting
   
   
 * Management Board: Highlights of October 2023 meeting
   
   Management Board |Highlights
   
   
   MANAGEMENT BOARD: HIGHLIGHTS OF OCTOBER 2023 MEETING
   
   
   
   
 * Management Board: Highlights of October 2023 meeting
   
   Management Board |Highlights
   
   
   MANAGEMENT BOARD: HIGHLIGHTS OF OCTOBER 2023 MEETING
   
   The Board adopted revised transparency rules for the Clinical Trials
   Information System and was updated on EMA’s activities in the first half of
   2023
   
   
 * Revision of transparency rules for clinical trials
   
   Clinical Trials |Regulatory
   
   
   REVISION OF TRANSPARENCY RULES FOR CLINICAL TRIALS
   
   
   
   
 * Revision of transparency rules for clinical trials
   
   Clinical Trials |Regulatory
   
   
   REVISION OF TRANSPARENCY RULES FOR CLINICAL TRIALS
   
   EMA revised rules to give faster access to information in the EU Clinical
   Trials Information System
   
   

Search for medicines
Search for information on human, veterinary or herbal medicines.

Search
What's new
Find all the latest news and updates published on this website in one place.

FAQs
Find answers to the most frequently asked questions we receive.



LATEST NEWS

 * List item
   18/10/2023
   
   
   EMA ALERTS EU PATIENTS AND HEALTHCARE PROFESSIONALS TO REPORTS OF FALSIFIED
   OZEMPIC PENS
   
   The European Medicines Agency has been notified by relevant national
   competent authorities that pre-filled pens falsely labelled as the diabetes
   medicine Ozempic (semaglutide, 1 mg, solution for injection) have been
   identified at wholesalers in the...
   
   
 * List item
   13/10/2023
   
   
   NEW TREATMENT OPTION FOR HEAVILY PRE-TREATED MULTIPLE MYELOMA PATIENTS
   
   EMA’s human medicines committee (CHMP) has recommended a conditional
   marketing authorisation in the European Union (EU) for Elrexfio (elranatamab)
   as a monotherapy (used on its own) for the treatment of adult patients with
   relapsed and refractory...
   
   
 * List item
   13/10/2023
   
   
   MEETING HIGHLIGHTS FROM THE COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE
   (CHMP) 9-12 OCTOBER 2023
   
   Seven new medicines recommended for approval EMA’s human medicines committee
   (CHMP) recommended seven medicines for approval at its October 2023 meeting.
   The CHMP adopted a positive opinion for Agamree * (vamorolone), for the
   treatment of Duchenne...
   
   
 * List item
   06/10/2023
   
   
   MEETING HIGHLIGHTS FROM THE COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
   (CVMP) 3-5 OCTOBER 2023
   
   The Committee adopted by consensus a positive opinion for a marketing
   authorisation Nobivac LoVo L4 (a duplicate of Nobivac L4), from Intervet
   International B.V., a vaccine for the active immunisation of of dogs against
   Leptospira interrogans...
   
   
 * List item
   06/10/2023
   
   
   EMA MANAGEMENT BOARD: HIGHLIGHTS OF OCTOBER 2023 MEETING
   
   EMA’s Management Board met on 5 October in Amsterdam. Clinical trials in the
   EU The Board adopted revised transparency rules for the publication of
   information on clinical trials submitted through the Clinical Trials
   Information System (CTIS). The...
   
   
 * List item
   06/10/2023
   
   
   REVISED TRANSPARENCY RULES FOR THE EU CLINICAL TRIALS INFORMATION SYSTEM
   (CTIS)
   
   EMA has adopted revised transparency rules for the publication of information
   on clinical trials submitted through the Clinical Trials Information System .
   The simplifications introduced will give access to clinical trial information
   to stakeholders...
   
   

 * Load more news


INFORMATION FOR YOU

Patients and carers
Featured news and updates for patients and carers
Healthcare professionals
Featured news and updates for healthcare professionals, including doctors,
nurses and pharmacists
Animal health professionals
Featured news and updates for animal health professionals and users of
veterinary medicines such as pet owners
Pharmaceutical industry
Featured news and updates for pharmaceutical industry stakeholders active in the
human and veterinary medicines fields
Media
Featured news and updates for journalists with a professional interest in the
development and availability of medicines in the European Union
Academia
Featured news and updates for European academics and researchers in the field of
medicine development


KEY CONTENT

 * List item
   
   
   PRODUCT EMERGENCY HOTLINE
   
   
   
   
 * List item
   
   
   UK’S WITHDRAWAL FROM THE EU
   
   
   
   
 * List item
   
   
   PRIME: PRIORITY MEDICINES
   
   
   
   
 * List item
   
   
   PHARMACOVIGILANCE (SAFETY MONITORING)
   
   
   
   
 * List item
   
   
   DATA ON MEDICINES
   
   
   
   
 * List item
   
   
   CLINICAL DATA PUBLICATION
   
   
   
   
 * List item
   
   
   CAREERS
   
   
   
   


SERVICES & DATABASES

 * List item
   
   
   CLINICAL TRIALS WEBSITE
   
   
   
   
 * List item
   
   
   ACCOUNT MANAGEMENT PORTAL
   
   
   
   
 * List item
   
   
   ESUBMISSION
   
   
   
   
 * List item
   
   
   EUDRAVIGILANCE (HUMAN)
   
   
   
   
 * List item
   
   
   EUDRAVIGILANCE VETERINARY
   
   
   
   
 * List item
   
   
   VETERINARY MEDICINES INFORMATION WEBSITE
   
   
   
   
 * List item
   
   
   SUSPECTED ADVERSE DRUG REACTIONS DATABASE
   
   
   
   
 * List item
   
   
   CLINICAL DATA
   
   
   
   
 * List item
   
   
   SPOR DATA MANAGEMENT SERVICES
   
   
   
   
 * List item
   
   
   SERVICE DESK
   
   
   
   
 * List item
   
   
   IRIS PLATFORM
   
   
   
   
 * List item
   
   
   PUBLIC REGISTER OF PARALLEL DISTRIBUTION NOTICES
   
   
   
   
 * List item
   
   
   EUROPEAN VACCINATION INFORMATION PORTAL
   
   
   
   


HOW DOES EMA WORK?

 * List item
   
   
   WHAT WE DO
   
   
   
   
 * List item
   
   
   OUR ROLE IN AUTHORISATION OF MEDICINES
   
   
   
   
 * List item
   
   
   WHO WE ARE
   
   
   
   
 * List item
   
   
   OUR SCIENTIFIC EXPERTS
   
   
   
   
 * List item
   
   
   HOW WE WORK
   
   
   
   
 * List item
   
   
   WHAT WE PUBLISH
   
   
   
   

Product emergency hotline
outside working hours
 * About us
 * What we do
 * Careers
 * Committees
 * Regulatory network

 * Languages
 * Frequently asked questions
 * Glossaries
 * About this website
 * Privacy

 * Search tips
 * Access to documents
 * Contacts
 * Send a question
 * EMA Service desk (system support)

European Medicines Agency
Domenico Scarlattilaan 6
1083 HS Amsterdam
The Netherlands

Tel: +31 (0)88 781 6000

How to find us

Postal address and deliveries

Business hours and holidays

For the United Kingdom, as of 1 January 2021, European Union law applies only to
the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on
Ireland / NI.
RSS feed Twitter YouTube LinkedIn
© 1995-2023 European Medicines Agency
European Union agencies network

An agency of the European Union